M. van Linde-Sibenius Trip

Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.

J. Rotter, A. Lusis, T. D. de Bruin, 1997, The Journal of clinical investigation.

Different postprandial metabolism of olive oil and soybean oil: a possible mechanism of the high-density lipoprotein conserving effect of olive oil.

T. D. de Bruin, D. Erkelens, C. Brouwer, 1993, The American journal of clinical nutrition.

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.

T. D. de Bruin, D. Erkelens, W. Kortlandt, 1993, Metabolism: clinical and experimental.

Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects.

T. D. de Bruin, H. van Barlingen, D. Erkelens, 1993, The Journal of clinical endocrinology and metabolism.

Lipoprotein(a) plasma concentrations associated with lipolytic activities in eight kindreds with familial combined hyperlipidemia and normolipidemic subjects.

T. D. de Bruin, M. Castro Cabezas, D. Erkelens, 1993, Metabolism: clinical and experimental.

The fraction of phosphatidylinositol that activates the (Na+ + K+)-ATPase in rabbit kidney microsomes is clearly associated with the enzyme protein.

B. Roelofsen, M. van Linde-Sibenius Trip, 1981, Biochimica et biophysica acta.

Apolipoprotein E2/E3/E4 genotyping with agarose gels.

T. D. de Bruin, G. Dallinga-Thie, M. van Linde-Sibenius Trip, 1995, Clinical chemistry.

Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III.

J. Rotter, A. Lusis, T. D. de Bruin, 1996, Journal of lipid research.

The phospholipid organisation in the membranes of McLeod and Leach phenotype erythrocytes

B. Roelofsen, M. Tanner, D. Anstee, 1985, FEBS letters.